The Investing News Network has created a series of free reports for investors, reviewing 2015 highlights and looking forward to 2016. With over 50 articles covering more than 40 investing topics, including insight and forecasts from hundreds of sources, these free reports offer incredible value to investors.
All new for 2016, these free reports are mobile and tablet friendly. That means you can take them to go or read these free reports at your leisure. Feel free to share with your friends and family — anyone you feel should be looking at the investing opportunities that 2016 presents.

Gold Trends 2015 and Gold Outlook 2016: Key Highlights for Investors

  • Gold Trends 2015: CEOs Recap the Year
  • 5 Top Gold News Stories of 2015
  • 5 TSX Best Gold Stocks 2015
  • Gold Forecast 2016: CEOs Cautiously Optimistic
  • Gold Outlook 2016: Analysts Calling for Sub-$1,000 Gold

 


Precious Metals Outlook: CEOs, Analysts on Gold, Silver, Platinum and Palladium

  • Gold Trends 2015: CEOs Recap the Year
  • Gold Forecast 2016: CEOs Cautiously Optimistic
  • Gold Outlook 2016: Analysts Calling for Sub-$1,000 Gold
  • Silver Predictions 2016: Watch China and the Gold Price
  • Top Silver Investment News of 2015
  • Platinum Price Forecast 2016: Market to Balance
  • Palladium Price Forecast 2016
  • Diamond Outlook 2016: Summer to Bring Higher Prices?

 

Base Metals in 2016: Opinions from Experts and CEO’s

  • Copper Price Forecast 2016: Producers Under Pressure
  • Copper Outlook 2016: Companies Weigh In
  • Zinc Forecast 2016: Will Strong Fundamentals Boost Price?
  • Iron Price Forecast for 2016 and Onward
  • Lead Outlook 2016: Watch China for Cues
  • Nickel Price Forecast 2016

 

Critical Metals Outlook: The Potential for 2016

  • Jon Hykawy of Stormcrow Capital Talks Rare Earth Prices 2015
  • Rare Earth Market Outlook 2016
  • Graphite Outlook 2016: Megafactory Deals on the Horizon?
  • Cobalt Outlook 2016: Near-term Deficit Still Expected
  • Tungsten Outlook: Does 2016 Have Potential?
  • Tantalum Price Trends 2015
  • Magnesium Mining Outlook 2016
  • Manganese Outlook 2016: Weak Steel Demand a Threat
  • Scandium Market Trends for 2015

 

Energy Investing Outlook: Moving Away from Carbon?

  • Uranium Outlook 2016: Supply Deficit in the Cards
  • Analysts Look Back at the Lithium Market in 2015
  • Junior Lithium Miners: 2015 in Review
  • Junior Mining Companies on the Lithium Outlook for 2016
  • Lithium Outlook 2016: What are Analysts Saying?
  • Oil Price Outlook 2016: Turnaround Targeted in late 2016
  • Natural Gas Outlook 2016: Prices to Stay Down on Oversupply

 

Lithium in 2016: Stocks, Prices, Analysts and CEOs

  • Junior Lithium Miners: 2015 in Review
  • Analysts Look Back at the Lithium Market in 2015
  • 10 Top Lithium News Stories of 2015
  • Junior Mining Companies on the Lithium Outlook for 2016
  • Lithium Outlook 2016: What are Analysts Saying?

 

Industrial Metals in 2016: Oversupply in Several Markets, but Not All

  • Coal in 2015: Another Tough Year
  • Coal Outlook 2016: Near-term Rebound Highly Unlikely
  • 5 Top Vanadium Articles of 2015
  • Aluminum Outlook 2016: Weakness to Prevail on Oversupplied Steel Industry
  • Tin Market Outlook 2016: Deficit to Linger into 2016
  • Molybdenum Outlook 2016: Oversupply Issues to Persist

 

Agriculture Investing Opportunities: Forecast for 2016

  • Investing in Cannabis 2016: Legalization and FDA Approvals to Revolutionize the Market
  • Potash Outlook 2016: SOP Expected to Shine
  • Phosphate Outlook: Steady Demand on the Horizon

 

Technology Investing in 2016: Trends and Outlooks for Successful Technology Investing

  • 2016 to Bring Big Changes for Cleantech Investors?
  • 3 Social Media Future Trends for 2016
  • Year in Review: The Bitcoin Market in 2015
  • Top Blockchain Investing Trends for 2016
  • Data Mining Trends for 2016
  • Investing in 3D Printer Companies in 2016
  • 3 Top App Investing Trends for 2016
  • Nanotechnology Future Outlook 2016
  • Graphene Market in 2016
  • Top Cybersecurity Trends for 2016
  • Cloud Computing Outlook 2016

 

Life Science Investing in 2016: Ethics, Apps and Revolution

  • Top Trends for Genomics Stocks in 2016
  • 2016 Outlook for Pharmaceutical Investors
  • Top Longevity Research Trends: Life Extension in 2016
  • Top Medical Device Trends for 2016
  • Top Trends for Biotech Companies in 2016

 

Have other topics you’d like us to cover?

Please let us know!

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less